^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TL-1-85

    i
    Other names: TL-1-85

    Associations

    News
    Trials
    Company:
    Massachusetts General Hospital, Wellcome Sanger Institute
    Drug class:
    TAK1 inhibitor, MAP4K2 inhibitor
    Related drugs:

    Associations

    News
    Trials